02741nam a22004695i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001200172072001700184072002300201072001600224245015700240250001800397264006900415300005300484336002600537337002600563338003600589347002400625520110300649650003001752650001801782650002501800650002101825650002701846650003401873650002101907700008401928710003402012773002602046776003602072776003602108776003602144856004602180912001402226912001402240999001702254978-3-031-52860-6DE-He21320251030112255.0cr nn 008mamaa240603s2024 sz | s |||| 0|eng d a97830315286069978-3-031-52860-67 a10.1007/978-3-031-52860-62doi 4aRC270.8 7aMJCL2bicssc 7aMED0620002bisacsh 7aMJCL2thema10aOvercoming Breast Cancer Therapy Resistanceh[electronic resource] :bFrom Mechanisms to Precision and AI-Powered Approaches /cedited by Zodwa Dlamini. a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024. aIX, 394 p. 74 illus. in color.bonline resource. atextbtxt2rdacontent acomputerbc2rdamedia aonline resourcebcr2rdacarrier atext filebPDF2rda aThis book addresses the pressing problem of drug resistance in the treatment of breast cancer. It provides a comprehensive understanding of the complex mechanisms underlying drug resistance and presents the latest advances in therapeutic approaches to overcome this enormous challenge. The book begins with an introduction to the biology of breast cancer, treatment modalities and the mechanisms of drug resistance. This includes the principles of drug resistance in targeted, immune-, endocrine and chemotherapy. In the following sections, the authors present innovative strategies to overcome drug resistance and new research directions, among others the role of the microbiome in drug resistance, molecular profiling of patients for personalized medical care, and new drug delivery systems. Finally, the book concludes with a discussion of the differences in the prevalence and treatment success of breast cancer between high- and low-income countries. This book is an informative resource for students, researchers, and clinicians in the field of breast cancer research and oncology in general. 0aCancerxTreatment.963722 0aCancer.94311 0aNanomedicine.964703 0aOncology.97076014aCancer Therapy.97341424aCancer Nanotechnology.97815424aOncology.9707601 aDlamini, Zodwa.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9781552 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303152859008iPrinted edition:z978303152861308iPrinted edition:z978303152862040uhttps://doi.org/10.1007/978-3-031-52860-6 aZDB-2-SBL aZDB-2-SXB c60472d60472